Summary & Overview
CPT 93923: Complete Bilateral Noninvasive Extremity Arterial Physiologic Study
CPT code 93923 is a critical diagnostic tool for evaluating arterial blood flow in the upper or lower extremities. This procedure, performed noninvasively at three or more levels or with provocative functional maneuvers, is widely used to detect and monitor peripheral arterial disease and other circulatory complications. The code encompasses a range of physiologic studies, including ankle/brachial indices, segmental blood pressure measurements, Doppler waveform analysis, plethysmography, and transcutaneous oxygen tension assessments.
Nationally, this service is covered by major payers such as Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare, reflecting its importance in vascular diagnostics. The procedure is typically conducted in vascular laboratories or outpatient diagnostic facilities, supporting timely and accurate assessment of patients with diabetes, atherosclerosis, chronic ulcers, and other vascular conditions.
Readers will gain insight into the clinical context of 93923, including its role in diagnosing and managing extremity arterial disease, payer coverage details, and relevant benchmarks. The publication also highlights policy updates and related codes, providing a comprehensive overview for healthcare professionals, administrators, and policy analysts seeking to understand the utilization and reimbursement landscape for this essential vascular diagnostic service.
CPT Code Overview
CPT code 93923 represents a complete bilateral noninvasive physiologic study of upper or lower extremity arteries at three or more levels, or a single level study with provocative functional maneuvers. This diagnostic procedure is used to assess arterial blood flow and detect vascular disease in the extremities. It typically involves measurements such as ankle/brachial indices, segmental blood pressure, bidirectional Doppler waveform recording and analysis, segmental volume plethysmography, or transcutaneous oxygen tension measurements. The service is commonly performed in a vascular laboratory or outpatient diagnostic facility, often designated as place of service 22 or 11. This non-invasive study is essential for evaluating patients with suspected peripheral arterial disease or other circulatory complications affecting the limbs.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with long-standing type 2 diabetes (E11.59) and progressive exertional leg pain presents to a vascular laboratory for noninvasive arterial testing. The clinician documents claudication of the right calf and a non-healing right thigh ulcer (L97.115). The vascular lab encounter includes review of history and vascular risk factors, focused vascular physical exam (pulses, bruits, skin integrity), and performance of noninvasive arterial diagnostic studies such as segmental blood pressures, plethysmography, and Doppler waveform analysis to evaluate arterial inflow and identify levels of stenosis or occlusion.
The typical clinical workflow: referral from primary care, endocrinology, or podiatry; scheduling in an accredited vascular lab; pre-procedure check for contraindications and laterality; performance of tests by a vascular technologist or sonographer; interpretation by a vascular surgeon, cardiologist, or diagnostic radiologist; and documentation of findings with correlation to the patients symptoms and wound status to guide revascularization planning or conservative management. Common payors for authorization and claims include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 |